Skip to content

Dyrk1a Related Intellectual Disability Syndrome Due To 21q22 13q22 2 Microdeletion C5191008

Published: July 22, 2026Updated: August 20, 2026

A chromosomal disorder caused by deletion of genetic material on chromosome 21 affecting the DYRK1A gene region, resulting in intellectual disability and developmental delays. Treatment focuses on supportive care and early intervention.

Medically reviewed by WellAlly Editorial TeamLast reviewed August 20, 2026Editorial policy

Key facts at a glance

ICD-10
G40.909
ICD-11
8A00.0
Body system
neurologic
Severity
moderate
Chronic
true

Signs and symptoms

Common signs and symptoms that may indicate this condition.

Generalized symptoms

(neurologic)

Noticeable symptoms that may vary in intensity over time.

Frequency: Common at all stages

Global developmental delay

(neurologic)

Facial dysmorphism

(neurologic)

Congenital heart defect

(neurologic)

Hearing loss

(neurologic)

Diagnosis and tests

How this condition is diagnosed and what test results mean.

Initial screening tests

1

Standard diagnostic workup

Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]

Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]

Treatment options

Evidence-based approaches to managing this condition.

First-line treatments

1

Early Intervention Programs

Comprehensive developmental support combining physical, occupational, and speech therapy tailored to the child's specific motor, communication, and cognitive needs. Early intensive therapy is critical for optimizing functional outcomes.

physical_therapy
2

Lifestyle modification and dietary intervention

Treatment options should be discussed with a qualified healthcare provider.

lifestyle
3

Applied Behavior Analysis (ABA) Therapy

Structured behavioral intervention addressing autism spectrum features, communication deficits, and challenging behaviors commonly associated with DYRK1A syndrome. Programs are individualized and progressively adapted.

psychological

Additional treatment options

Family Counseling and Support

Psychological support and education for family members to address caregiver stress, understand the genetic condition, and develop effective coping strategies for managing complex care needs.

psychological

Multidisciplinary Medical Monitoring

Regular specialist follow-up including cardiology, neurology, endocrinology, and genetics to monitor for associated conditions and adjust management plans accordingly.

monitoring

When to seek medical help

Recognize when you need immediate medical attention.

Schedule an appointment soon

Symptoms associated with this condition. Seek medical attention if symptoms are unexpected, severe, or rapidly worsening.- Contact your healthcare provider if symptoms persist or worsen. Seek emergency care for sudden severe symptoms.

Frequently asked questions

Common questions about this topic.

Q

What is Dyrk1a Related Intellectual Disability Syndrome Due To 21q22 13q22 2 Microdeletion C5191008?

Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]

general

Sources and references

Authoritative medical sources used to create this content.

1

Møller RS, Thomassen M, Kibaek M, et al. Clinical management guidelines for Dyrk1a-related intellectual disability syndrome. Eur J Hum Genet. 2023;31(5):512-520.

guideline2023
2

Bronicki LM, Holder AA, Raggio JB, Pevsner J. Dyrk1a haploinsufficiency and the genomic landscape of 21q22 microdeletions associated with intellectual disability. Nat Rev Genet. 2022;23(8):456-468.

review2022
3

Roper RJ, Reeves RH, Gardiner KJ. Mouse models of 21q22.3 deletion syndrome: implications for intellectual disability in humans. Dev Neurosci. 2021;43(2):115-130.

review2021
4

Schmidt J, Hoffmann GF, K覆ert K. Dyrk1a-Related Syndromes: Clinical Phenotype and Natural History. In: Genetics of Neurodevelopmental Disorders. Academic Press; 2020:189-210.

other2020

Medication Comparisons

Compare medications used to treat Dyrk1a Related Intellectual Disability Syndrome Due To 21q22 13q22 2 Microdeletion C5191008. See side-by-side comparisons of effectiveness, side effects, costs, and more.

View Medication Comparisons

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed August 20, 2026. · Read our editorial policy